Combination product of a 1,4-benzothiepine 1,1-dioxide compound with at least one other active ingredient and the use of the product

US7179792B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Heiner Glombik · Hofheim, DE
• Wendelin Frick · Bad Camberg, DE
• Hans-Ludwig Schaefer · Frankfurt am Main, DE
• Werner Kramer · Schwandorf, DE

Key dates

• Filing date: Nov 3, 2003
• Grant date: Feb 20, 2007
• Expiry date: Nov 3, 2023

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention is directed to a 1,4-benzothiepine 1,1-dioxide compound of formula Iin which the radicals have the meanings defined herein, or a pharmaceutically acceptable salt or physiologically functional derivative thereof, with at least one other active ingredient, or a pharmaceutically acceptable salt or physiologically functional derivative thereof. The invention is also directed to the use of the combination product, pharmaceutical composition comprising the combination product and method for preparing the pharmaceutical composition.